Recombinant Human Activated Protein C in the Treatment of Acute Respiratory Distress Syndrome: A Randomized Clinical Trial

Respiratory Distress ◽

Protein C ◽

Distress Syndrome ◽

Activated Protein C

Faculty Opinions recommendation of Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure-Guided Strategy vs an Empirical High PEEP-Fio2 Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735110597.793560070 ◽

2019 ◽

Author(s):

Jesús Villar

Keyword(s):

Clinical Trial ◽

Mechanical Ventilation ◽

Respiratory Distress ◽

Distress Syndrome ◽

Esophageal Pressure ◽

High Peep ◽

Positive End Expiratory Pressure

Nebulized activated protein C in a paediatric patient with severe acute respiratory distress syndrome secondary to H1N1 influenza

British Journal of Anaesthesia ◽

10.1093/bja/aer316 ◽

2011 ◽

Vol 107 (5) ◽

pp. 818-819 ◽

Cited By ~ 1

Author(s):

D. Pestaña ◽

P. de la Oliva

Keyword(s):

Paediatric Patient ◽

Respiratory Distress ◽

Protein C ◽

Distress Syndrome ◽

Activated Protein C ◽

H1n1 Influenza

Activated protein C attenuates pulmonary coagulopathy in patients with acute respiratory distress syndrome

Journal of Thrombosis and Haemostasis ◽

10.1111/jth.12179 ◽

2013 ◽

Vol 11 (5) ◽

pp. 894-901 ◽

Cited By ~ 16

Author(s):

A. D. Cornet ◽

J. J. Hofstra ◽

A. P. Vlaar ◽

P. R. Tuinman ◽

M. Levi ◽

...

Keyword(s):

Respiratory Distress ◽

Protein C ◽

Distress Syndrome ◽

Activated Protein C

Recombinant human activated protein C reduces cardiac 3-nitrotyrosine and malondialdehyde levels in ovine acute respiratory distress syndrome and septic shock

Critical Care ◽

10.1186/cc7498 ◽

2009 ◽

Vol 13 (Suppl 1) ◽

pp. P334

Author(s):

MO Maybauer ◽

DM Maybauer ◽

JF Fraser ◽

L Kiss ◽

C Szabo ◽

...

Keyword(s):

Septic Shock ◽

Respiratory Distress ◽

Protein C ◽

Distress Syndrome ◽

Activated Protein C

Faculty Opinions recommendation of Randomized clinical trial of a combination of an inhaled corticosteroid and beta agonist in patients at risk of developing the acute respiratory distress syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727348815.793567309 ◽

2019 ◽

Author(s):

Kathryn Anne Hibbert

Keyword(s):

Clinical Trial ◽

At Risk ◽

Respiratory Distress ◽

Distress Syndrome ◽

Beta Agonist ◽

Inhaled Corticosteroid ◽

Patients At Risk

Combined use of extracorporeal membrane oxygenation and activated protein C for severe acute respiratory distress syndrome and septic shock

Journal of Thoracic and Cardiovascular Surgery ◽

10.1016/j.jtcvs.2008.05.030 ◽

2009 ◽

Vol 138 (1) ◽

pp. 246-247 ◽

Cited By ~ 5

Author(s):

Yoan Lamarche ◽

Anson Cheung ◽

Keith R. Walley ◽

Peter Dodek

Keyword(s):

Septic Shock ◽

Extracorporeal Membrane Oxygenation ◽

Respiratory Distress ◽

Protein C ◽

Distress Syndrome ◽

Activated Protein C ◽

Membrane Oxygenation ◽

Combined Use

Activated protein C versus placebo in the treatment of INFlammatory or infectious Acute Lung Injury/acute respiratory distress syndrome (INFALI): a pathophysiological study on pulmonary microvascular permeability, apoptosis, inflammation and coagulation

http://isrctn.org/> ◽

10.1186/isrctn52566874 ◽

2012 ◽

Author(s):

A Beishuizen

Keyword(s):

Acute Lung Injury ◽

Lung Injury ◽

Respiratory Distress ◽

Protein C ◽

Distress Syndrome ◽

Activated Protein C ◽

Microvascular Permeability

Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality

Infectious Diseases and Therapy ◽

10.1007/s40121-018-0192-3 ◽

2018 ◽

Vol 7 (S1) ◽

pp. 15-25 ◽

Cited By ~ 3

Author(s):

Katerina Kaziani ◽

Alice G. Vassiliou ◽

Anastasia Kotanidou ◽

Chariclea Athanasiou ◽

Ioanna Korovesi ◽

...

Keyword(s):

Endothelial Dysfunction ◽

Endothelial Function ◽

Respiratory Distress ◽

Protein C ◽

Distress Syndrome ◽

Activated Protein C ◽

Pulmonary Capillary ◽

Syndrome Association

Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease

American Heart Journal ◽

10.1016/j.ahj.2020.05.010 ◽

2020 ◽

Vol 226 ◽

pp. 60-68 ◽

Cited By ~ 4

Author(s):

D. H. Frank Gommans ◽

Joris Nas ◽

Sara-Joan Pinto-Sietsma ◽

Yvonne Koop ◽

Regina E. Konst ◽

...

Keyword(s):

Clinical Trial ◽

Respiratory Distress ◽

Distress Syndrome ◽

Hospitalized Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Infection Disease

Faculty Opinions recommendation of Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.731684831.793572537 ◽

2020 ◽

Author(s):

Jeremy Beitler

Keyword(s):

Clinical Trial ◽

Respiratory Distress ◽

Distress Syndrome ◽

Lung Recruitment ◽

Positive End Expiratory Pressure